Sudeep Pharma · NSE: SUDEEPPHRM · BSE: 544619

Q1 FY27 results · Apr–Jun 2026

Sudeep Pharma reported revenue from operations of ₹158.27 crore and net profit of ₹40.59 crore for Q1 FY27 (Apr–Jun 2026), on a consolidated basis.

Consolidated · ₹ crore
Item	Q1 FY27	Q1 FY26	YoY	Q4 FY26	QoQ
Revenue from operations	158.27	—	—	182.34	−13.2%
Other income	5.45	—	—	6.42	−15.2%
Total income	163.72	—	—	188.76	−13.3%
Profit before tax	54.29	—	—	62.69	−13.4%
Net profit for the period	40.59	—	—	48.54	−16.4%
Attributable to shareholders of the company	40.55	—	—	48.88	−17.0%
EPS, basic (₹)	3.59	—	—	4.38	−18.0%
Net margin (%)	25.6	—		26.6

Standalone · ₹ crore
Item	Q1 FY27	Q1 FY26	YoY	Q4 FY26	QoQ
Revenue from operations	105.68	—	—	80.17	+31.8%
Other income	9.80	—	—	9.62	+1.9%
Total income	115.48	—	—	89.79	+28.6%
Profit before tax	45.41	—	—	34.74	+30.7%
Net profit for the period	33.83	—	—	25.77	+31.3%
EPS, basic (₹)	3.00	—	—	2.31	+29.9%
Net margin (%)	32.0	—		32.1

Consolidated

Standalone